Emily Glogowski

1.0k total citations
27 papers, 530 citations indexed

About

Emily Glogowski is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology. According to data from OpenAlex, Emily Glogowski has authored 27 papers receiving a total of 530 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pathology and Forensic Medicine, 11 papers in Genetics and 7 papers in Oncology. Recurrent topics in Emily Glogowski's work include Genetic factors in colorectal cancer (11 papers), BRCA gene mutations in cancer (10 papers) and Colorectal Cancer Screening and Detection (7 papers). Emily Glogowski is often cited by papers focused on Genetic factors in colorectal cancer (11 papers), BRCA gene mutations in cancer (10 papers) and Colorectal Cancer Screening and Detection (7 papers). Emily Glogowski collaborates with scholars based in United States, Canada and Australia. Emily Glogowski's co-authors include Kenneth Offit, Khédoudja Nafa, Nathan A. Ellis, Mark E. Robson, David W. Kissane, Catharine Whiteside, Carma L. Bylund, Carla L. Fisher, Murray F. Brennan and Robert G. Maki and has published in prestigious journals such as Cancer, Annals of Surgery and Clinical Cancer Research.

In The Last Decade

Emily Glogowski

26 papers receiving 522 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emily Glogowski United States 14 172 152 117 97 89 27 530
C. Seynaeve Netherlands 16 210 1.2× 90 0.6× 52 0.4× 299 3.1× 163 1.8× 37 668
Annika Bergman Sweden 13 211 1.2× 194 1.3× 99 0.8× 143 1.5× 110 1.2× 18 689
Nicholas Pachter Australia 14 210 1.2× 44 0.3× 233 2.0× 67 0.7× 123 1.4× 30 578
Shelly S. Lo United States 10 140 0.8× 66 0.4× 133 1.1× 286 2.9× 105 1.2× 37 591
Irena Liphshitz Israel 16 58 0.3× 92 0.6× 113 1.0× 328 3.4× 86 1.0× 38 712
Elizabeth C. Bluhm United States 9 198 1.2× 303 2.0× 80 0.7× 232 2.4× 72 0.8× 12 737
R Davidson United Kingdom 9 346 2.0× 77 0.5× 159 1.4× 120 1.2× 28 0.3× 12 511
Isabelle Coupier France 14 274 1.6× 73 0.5× 255 2.2× 96 1.0× 108 1.2× 35 834
Corey Pelletier United States 17 43 0.3× 83 0.5× 184 1.6× 259 2.7× 235 2.6× 76 841
A. H. J. T. Vriends Netherlands 15 130 0.8× 82 0.5× 113 1.0× 137 1.4× 28 0.3× 18 662

Countries citing papers authored by Emily Glogowski

Since Specialization
Citations

This map shows the geographic impact of Emily Glogowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Glogowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Glogowski more than expected).

Fields of papers citing papers by Emily Glogowski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily Glogowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Glogowski. The network helps show where Emily Glogowski may publish in the future.

Co-authorship network of co-authors of Emily Glogowski

This figure shows the co-authorship network connecting the top 25 collaborators of Emily Glogowski. A scholar is included among the top collaborators of Emily Glogowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily Glogowski. Emily Glogowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mighton, Chloe, Marc Clausen, Salma Shickh, et al.. (2023). How do members of the public expect to use variants of uncertain significance in their health care? A population-based survey. Genetics in Medicine. 25(5). 100819–100819. 2 indexed citations
2.
Mighton, Chloe, Marc Clausen, Salma Shickh, et al.. (2021). Patient and public preferences for being recontacted with updated genomic results: a mixed methods study. Human Genetics. 140(12). 1695–1708. 7 indexed citations
3.
Mighton, Chloe, Lindsay Carlsson, Marc Clausen, et al.. (2020). Quality of life drives patients’ preferences for secondary findings from genomic sequencing. European Journal of Human Genetics. 28(9). 1178–1186. 17 indexed citations
4.
Formea, Christine M., et al.. (2020). PARC report: A Perspective on the state of Clinical Pharmacogenomics Testing. Pharmacogenomics. 21(11). 809–820. 9 indexed citations
5.
Bombard, Yvonne, Marc Clausen, Chloe Mighton, et al.. (2018). The Genomics ADvISER: development and usability testing of a decision aid for the selection of incidental sequencing results. European Journal of Human Genetics. 26(7). 984–995. 36 indexed citations
6.
Stratton, Kelly, Shaheen Alanee, Emily Glogowski, et al.. (2015). Outcome of genetic evaluation of patients with kidney cancer referred for suspected hereditary cancer syndromes. Urologic Oncology Seminars and Original Investigations. 34(5). 238.e1–238.e7. 16 indexed citations
7.
Salerno, Mariacarolina, Margaret Sheehan, Megan Harlan Fleischut, et al.. (2015). Decision Making about Contralateral Prophylactic Mastectomy Among BRCA1/2 Noncarriers with Newly-diagnosed Breast Cancer: Examining Cognitive, Emotional, and Sociodemographic Influences. Cancer Epidemiology Biomarkers & Prevention. 24(4). 760–760.
8.
Feero, W, Flavia M. Facio, Emily Glogowski, et al.. (2014). Preliminary validation of a consumer-oriented colorectal cancer risk assessment tool compatible with the US Surgeon General’s My Family Health Portrait. Genetics in Medicine. 17(9). 753–756. 7 indexed citations
9.
Arnold, Angela G., Ebunoluwa Otegbeye, Megan Harlan Fleischut, et al.. (2014). Assessment of individuals with BRCA1 and BRCA2 large rearrangements in high-risk breast and ovarian cancer families. Breast Cancer Research and Treatment. 145(3). 625–634. 9 indexed citations
10.
Fisher, Carla L., Erin K. Maloney, Emily Glogowski, et al.. (2014). Talking About Familial Breast Cancer Risk. Qualitative Health Research. 24(4). 517–535. 24 indexed citations
11.
Farrell, Michael, David J. Hughes, Ian Berry, et al.. (2012). Clinical correlation and molecular evaluation confirm that the MLH1 p.Arg182Gly (c.544A>G) mutation is pathogenic and causes Lynch syndrome. Familial Cancer. 11(3). 509–518. 3 indexed citations
12.
Lee-Kong, Steven A., Arnold J. Markowitz, Emily Glogowski, et al.. (2010). Prospective Immunohistochemical Analysis of Primary Colorectal Cancers for Loss of Mismatch Repair Protein Expression. Clinical Colorectal Cancer. 9(4). 255–259. 10 indexed citations
13.
Guillem, José G., Emily Glogowski, Harvey G. Moore, et al.. (2007). Single-amplicon MSH2 A636P Mutation Testing in Ashkenazi Jewish Patients With Colorectal Cancer. Annals of Surgery. 245(4). 560–565. 7 indexed citations
14.
Peterlongo, Paolo, Nandita Mitra, Miguel de la Hoya, et al.. (2006). Increased frequency of disease-causing MYH mutations in colon cancer families. Carcinogenesis. 27(11). 2243–2249. 39 indexed citations
15.
Robson, Mark E., Emily Glogowski, Gunhild Sommer, et al.. (2004). Pleomorphic Characteristics of a Germ-Line KIT Mutation in a Large Kindred with Gastrointestinal Stromal Tumors, Hyperpigmentation, and Dysphagia. Clinical Cancer Research. 10(4). 1250–1254. 86 indexed citations
16.
Peterlongo, Paolo, Khédoudja Nafa, Emily Glogowski, et al.. (2003). MSH6 germline mutations are rare in colorectal cancer families. International Journal of Cancer. 107(4). 571–579. 42 indexed citations
17.
Guillem, José G., Beth Rapaport, Tomas Kirchhoff, et al.. (2003). A636P is Associated with Early-Onset Colon Cancer in Ashkenazi Jews. Journal of the American College of Surgeons. 196(2). 222–225. 20 indexed citations
18.
Kauff, Noah D., Lauren Scheuer, Mark E. Robson, et al.. (2001). Insurance reimbursement for risk-reducing mastectomy and oophorectomy in women with BRCA1 or BRCA2 mutations. Genetics in Medicine. 3(6). 422–425. 16 indexed citations
19.
Glogowski, Emily, Evangelia Tsiani, Xiaopeng Zhou, I. George Fantus, & Catharine Whiteside. (1999). High glucose alters the response of mesangial cell protein kinase C isoforms to endothelin-1. Kidney International. 55(2). 486–499. 37 indexed citations
20.
Babazono, Tetsuya, et al.. (1998). High glucose-induced mesangial cell altered contractility: role of the polyol pathway. Diabetologia. 41(5). 507–515. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C. Seynaeve Breakdown of academic impact, for papers by Annika Bergman Breakdown of academic impact, for papers by Nicholas Pachter Breakdown of academic impact, for papers by Shelly S. Lo Breakdown of academic impact, for papers by Irena Liphshitz Breakdown of academic impact, for papers by Elizabeth C. Bluhm Breakdown of academic impact, for papers by R Davidson Breakdown of academic impact, for papers by Isabelle Coupier Breakdown of academic impact, for papers by Corey Pelletier Breakdown of academic impact, for papers by A. H. J. T. Vriends
Rankless by CCL
2026